|
|
The Iodine Group | |
|
Home | Orthoiodosupplementation | Body | Disease | Special | Overviews |
||
|
|
Patton
Recent advances in thyroid imaging.Sandler MP, Patton JA, Ossoff RH. Otolaryngol Clin North Am. 1990 Apr;23(2):251-70. Review. [abstract only]
"Thyroid imaging has evolved from early radionuclide rectilinear thyroid scanning to the recently developed technique of single photon emission computed tomography. At the same time, x-ray fluorescent scanning, ultrasound, computed tomography, magnetic resonance imaging, and positron emission tomography have improved identification of the thyroid gland. The appropriate use and relative roles of these imaging modalities in the investigation of patients with thyroid disease are discussed."
Serial thyroid iodine content in hyperthyroid patients treated with radioiodine.Lee GS, Sandler MP, Patton JA, Brill AB. Clin Nucl Med. 1986 Feb;11(2):115-8. [abstract only]
"X-ray fluorescent scanning was used to measure initial thyroidal iodine content in 64 patients diagnosed as being hyperthyroid and selected for I-131 therapy, and serially in 48 of these patients after therapy in an attempt to determine those patients that were at high risk of becoming hypothyroid. Iodine content fell rapidly after therapy, reaching a nadir at about three months. Based on the population studied, the chance of early hypothyroidism (within 12 months) is about 80% if the iodine content measured at three months is less than 2 mg. If the iodine content is greater than 2 mg, the chance is only about 14%. The serial measurement of thyroidal iodine content (with x-ray fluorescent scanning) may allow early identification of those patients at high risk of developing permanent hypothyroidism following a therapeutic dose of I-131."
Prediction of benignancy of the solitary "cold" thyroid nodule by fluorescent scanning.Patton JA, Sandler MP, Partain CL. J Nucl Med. 1985 May;26(5):461-4. [abstract only]
"A quantitative x-ray fluorescent scanning technique has been used routinely to determine iodine content ratios (ICR) of nodule to normal thyroid tissue in patients with solitary "cold" thyroid nodules. A study of 150 patients with histological diagnoses has shown that an ICR above 0.60 is an excellent indicator of benignancy with a sensitivity of 63% and a specificity of 99%. This technique, in conjunction with careful clinical judgment, can be used to identify those patients that are at low risk for malignancy and can probably undergo conservative clinical management."
Simultaneous emission and fluorescent scanning of the thyroid.Patton JA, Brill AB.
"A comparison study of lithium-drifted silicon [Si(Li)] and high purity germanium (HpGe) was performed to explore the feasibility of replacing the current Si(Li) detector with the higher-efficiency HpGe detector. The improved efficiency of HpGe permits the use of collimators with higher resolution, which results in improved image quality over that achieved by the current Si(Li) system in use at Vanderbilt with an overall reduction in sensitivity of 29%. Since a 10 mm thick HpGe detector is about 75% efficient at 140 keV, the added advantage exists of simultaneously (a) imaging the stable-iodine distribution within the thyroid by x-ray fluorescence, and (b) the distribution of administered radiotracers such as [99mTc] pertechnetate. This comparison study shows that HpGe can compete with Si(Li) in overall detector efficiency, with the added benefits of better collimation to improve spatial resolution plus the simultaneous imaging of Tc-99m, all at the same equipment cost."
Differentiation between malignant and benign solitary thyroid nodules by fluorescent scanning.Patton JA, Hollifield JW, Brill AB, Lee GS, Patton DD. J Nucl Med. 1976 Jan;17(1):17-21.
"A quantitative fluorescent technique has been developed for making in vivo iodine content determinations of the total thyroid gland or of selected parts. In solitary thyroid nodules "cold" to radionuclide studies, the ratio of iodine content in the nodule to that in a corresponding area of the contralateral lobe has proven to be a good indicator of malignancy. In a preliminary study of 42 surgical patients, an iodine content ratio (ICR) below 0.60 (chosen a posteriori) proved to be an excellent indication of malignancy with a sensitivity of 100%, a specificity (predictive value) of 79%, and an overall accuracy of 90%. Further definitive studies are needed to verify these preliminary observations."
|
|
Home | Orthoiodosupplementation | Body | Disease | Special Topics | OverviewsThe Iodine Group | Books | Disclaimers | Contact Us | Search
|
||
